Clinical trial
A Comparison of Immunogenicity of Licensed RSV Vaccines in Residents of Long-Term Care Facilities (LTCF) to Community-dwelling Older Adults
NCT06077149 is registered in ClinicalTrials.gov with University of Rochester as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Comparison of Immunogenicity of Licensed RSV Vaccines in Residents of Long-Term Care Facilities (LTCF) to Community-dwelling Older Adults
- Lead sponsor
- University of Rochester
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 7, 2023
- Completion date
- November 1, 2024
- Enrollment
- 152 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
respiratory syncytial virus (rsv)